• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名患有乳腺癌和微卫星低度不稳定皮肤鳞状细胞癌的女性的穆尔-托雷综合征病例报告。

A case report of Muir-Torre syndrome in a woman with breast cancer and MSI-Low skin squamous cell carcinoma.

作者信息

Kientz Caroline, Joly Marie-Odile, Faivre Laurence, Clemenson Alix, Dalac Sophie, Lepage Côme, Chapusot Caroline, Jacquot Caroline, Schiappa Renaud, Lebrun Marine

机构信息

Department of Genetics, Hôpital Nord, CHU Saint Etienne, 42055 Saint-Etienne Cedex 2, France.

Department of Central Anatomy and Pathological Cytology, Edouard Herriot Hospital, Hospices Civils de Lyon, 69437 Lyon Cedex 3, France.

出版信息

Hered Cancer Clin Pract. 2017 May 12;15:6. doi: 10.1186/s13053-017-0066-9. eCollection 2017.

DOI:10.1186/s13053-017-0066-9
PMID:28507641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5429559/
Abstract

BACKGROUND

The tumor spectrum in the Lynch syndrome is well defined, comprising an increased risk of developing colonic and extracolonic malignancies. Muir-Torre syndrome is a variant with a higher risk of skin disease. Patients have been described carrying mutations in the mismatch repair genes and presenting tumors with unusual histology or affected organ not part of the Lynch syndrome spectrum. Hence, the real link between Lynch syndrome, or Muir-Torre syndrome, and these tumors remains difficult to assess.

CASE PRESENTATION

We present the case of a 45-year-old-woman, diagnosed with breast cancer at 39 years of age and skin squamous cell carcinoma (SCC) at 41 years of age, without personal history of colorectal cancer. The microsatellite instability analysis performed on the skin SCC showed a low-level of microsatellite instability (MSI-Low). The immunohistochemical expression analysis of the four DNA mismatch repair proteins MLH1, MSH2, MSH6 and PMS2 showed a partial loss of the expression of MSH2 and MSH6 proteins. Germline deletion was found in gene (c.1277-? _1661 + ?del), exon 8 to 10. Then, at 45 years of age, she presented hyperplastic polyps of the colon and a sebaceous adenoma.

CONCLUSION

Squamous cell carcinomas have been described in Lynch syndrome and Muir-Torre syndrome in two studies and two case reports. This new case further supports a possible relationship between Lynch syndrome and squamous cell carcinoma.

摘要

背景

林奇综合征中的肿瘤谱已明确界定,包括患结肠和结肠外恶性肿瘤风险增加。穆尔-托综合征是一种皮肤疾病风险更高的变异型。已描述携带错配修复基因突变且出现组织学异常或受累器官不属于林奇综合征谱的肿瘤患者。因此,林奇综合征或穆尔-托综合征与这些肿瘤之间的真正联系仍难以评估。

病例报告

我们报告一例45岁女性病例,该患者39岁时被诊断为乳腺癌,41岁时被诊断为皮肤鳞状细胞癌(SCC),无结直肠癌个人史。对皮肤SCC进行的微卫星不稳定性分析显示微卫星不稳定性水平较低(微卫星低度不稳定,MSI-Low)。对四种DNA错配修复蛋白MLH1、MSH2、MSH6和PMS2的免疫组化表达分析显示MSH2和MSH6蛋白表达部分缺失。在基因(c.1277-?_1661 + ?del)外显子8至10中发现胚系缺失。然后,在45岁时,她出现了结肠增生性息肉和皮脂腺腺瘤。

结论

两项研究和两篇病例报告中均描述了林奇综合征和穆尔-托综合征中的鳞状细胞癌。这一新病例进一步支持了林奇综合征与鳞状细胞癌之间可能存在的关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70bf/5429559/6229a0cebc54/13053_2017_66_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70bf/5429559/c01834fa482f/13053_2017_66_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70bf/5429559/3aa77307eb21/13053_2017_66_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70bf/5429559/87d3ca11330c/13053_2017_66_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70bf/5429559/6229a0cebc54/13053_2017_66_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70bf/5429559/c01834fa482f/13053_2017_66_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70bf/5429559/3aa77307eb21/13053_2017_66_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70bf/5429559/87d3ca11330c/13053_2017_66_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70bf/5429559/6229a0cebc54/13053_2017_66_Fig4_HTML.jpg

相似文献

1
A case report of Muir-Torre syndrome in a woman with breast cancer and MSI-Low skin squamous cell carcinoma.一名患有乳腺癌和微卫星低度不稳定皮肤鳞状细胞癌的女性的穆尔-托雷综合征病例报告。
Hered Cancer Clin Pract. 2017 May 12;15:6. doi: 10.1186/s13053-017-0066-9. eCollection 2017.
2
Germline Testing of Mismatch Repair Genes Is Needed in the Initial Evaluation of Patients With Muir-Torre Syndrome-Associated Cutaneous Sebaceous Neoplasms: A Case Series.穆尔-托雷综合征相关皮肤皮脂腺肿瘤患者初始评估中需要进行错配修复基因的种系检测:病例系列
Cureus. 2023 Jan 19;15(1):e33975. doi: 10.7759/cureus.33975. eCollection 2023 Jan.
3
Muir-Torre Syndrome and founder mismatch repair gene mutations: A long gone historical genetic challenge.穆尔-托雷综合征与奠基者错配修复基因突变:一个早已远去的历史遗传学挑战。
Gene. 2016 Sep 10;589(2):127-32. doi: 10.1016/j.gene.2015.06.078. Epub 2015 Jul 2.
4
Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome.通用错配修复蛋白免疫组化在皮脂腺肿瘤患者中作为穆尔-托里综合征初始筛查工具的重要性。
Hum Pathol. 2016 Mar;49:1-9. doi: 10.1016/j.humpath.2015.10.005. Epub 2015 Oct 31.
5
The frequency of Muir-Torre syndrome among Lynch syndrome families.林奇综合征家族中穆尔-托综合征的发病率。
J Natl Cancer Inst. 2008 Feb 20;100(4):277-81. doi: 10.1093/jnci/djm291. Epub 2008 Feb 12.
6
A Case of Muir-Torre Syndrome.穆尔-托雷综合征一例。
Cureus. 2021 Apr 20;13(4):e14582. doi: 10.7759/cureus.14582.
7
Somatic MMR gene mutations as a cause for MSI-H sebaceous neoplasms in Muir-Torre syndrome-like patients.体细胞错配修复基因突变为穆尔-托雷综合征样患者中微卫星高度不稳定皮脂腺肿瘤的病因。
Hum Mutat. 2015 Mar;36(3):292-5. doi: 10.1002/humu.22740.
8
Case Report: A Frameshift Mutation in MSH2 Exon 2 in a Kidney Recipient With Muir-Torre Syndrome.病例报告:一名患有穆尔-托雷综合征的肾移植受者MSH2基因第2外显子的移码突变
Front Oncol. 2021 Jun 24;11:681780. doi: 10.3389/fonc.2021.681780. eCollection 2021.
9
Clinical and Molecular Features of Skin Malignancies in Muir-Torre Syndrome.穆尔-托雷综合征皮肤恶性肿瘤的临床和分子特征
Genes (Basel). 2021 May 20;12(5):781. doi: 10.3390/genes12050781.
10
Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test.穆尔-托雷综合征以及MSH2或MLH1种系突变患者皮肤肿瘤中DNA错配修复蛋白的缺失:免疫组织化学分析作为筛查试验的确立
Am J Surg Pathol. 2002 Mar;26(3):338-43. doi: 10.1097/00000478-200203000-00007.

引用本文的文献

1
An Unusual Presentation of Synchronous Breast Cancer and Skin Malignancy in a Patient with Lynch Syndrome: A Case Report and Review of the Literature.林奇综合征患者同步发生乳腺癌和皮肤恶性肿瘤的罕见表现:一例病例报告及文献复习
Biomedicines. 2024 Jun 3;12(6):1242. doi: 10.3390/biomedicines12061242.
2
Clinical and Molecular Features of Skin Malignancies in Muir-Torre Syndrome.穆尔-托雷综合征皮肤恶性肿瘤的临床和分子特征
Genes (Basel). 2021 May 20;12(5):781. doi: 10.3390/genes12050781.
3
Cutaneous Squamous Cell Carcinoma in Lynch Syndrome - An Overlooked Association.

本文引用的文献

1
Lynch syndrome caused by MLH1 mutations is associated with an increased risk of breast cancer: a cohort study.一项队列研究表明,由MLH1基因突变引起的林奇综合征与乳腺癌风险增加相关。
J Med Genet. 2015 Aug;52(8):553-6. doi: 10.1136/jmedgenet-2015-103216. Epub 2015 Jun 22.
2
A case of squamous cell carcinoma of the skin due to the molecularly confirmed Lynch Syndrome.一例经分子学确诊为林奇综合征的皮肤鳞状细胞癌病例。
Hered Cancer Clin Pract. 2015 May 16;13(1):12. doi: 10.1186/s13053-015-0033-2. eCollection 2015.
3
Lynch syndrome: five unanswered questions.
林奇综合征中的皮肤鳞状细胞癌——一种被忽视的关联
Cureus. 2021 Feb 25;13(2):e13553. doi: 10.7759/cureus.13553.
4
Genetic heterogeneity in a patient with Muir-Torre syndrome.穆尔-托雷综合征患者的基因异质性。
JAAD Case Rep. 2020 Jul 9;6(9):886-891. doi: 10.1016/j.jdcr.2020.07.006. eCollection 2020 Sep.
5
A squamous cell carcinoma in a young woman with Lynch syndrome.一位患有林奇综合征的年轻女性患有鳞状细胞癌。
Fam Cancer. 2019 Apr;18(2):193-196. doi: 10.1007/s10689-018-00113-5.
林奇综合征:五个未解决的问题。
Clin Genet. 2015 Jun;87(6):503-6. doi: 10.1111/cge.12580.
4
First reported case of a squamous cell carcinoma arising in the duodenum in a patient with Lynch syndrome.首例林奇综合征患者十二指肠发生鳞状细胞癌的病例报告。
Int J Clin Exp Pathol. 2014 Dec 1;7(12):8988-95. eCollection 2014.
5
Risk of breast cancer in Lynch syndrome: a systematic review.林奇综合征患者患乳腺癌的风险:一项系统综述。
Breast Cancer Res. 2013 Mar 19;15(2):R27. doi: 10.1186/bcr3405.
6
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts.林奇综合征(HNPCC)临床管理的修订指南:一组欧洲专家的建议。
Gut. 2013 Jun;62(6):812-23. doi: 10.1136/gutjnl-2012-304356. Epub 2013 Feb 13.
7
Risks of less common cancers in proven mutation carriers with lynch syndrome.林奇综合征明确突变携带者中少见癌症的风险。
J Clin Oncol. 2012 Dec 10;30(35):4409-15. doi: 10.1200/JCO.2012.43.2278. Epub 2012 Oct 22.
8
Clinical relevance of microsatellite instability in colorectal cancer.结直肠癌中微卫星不稳定性的临床相关性。
J Clin Oncol. 2010 Jul 10;28(20):3380-7. doi: 10.1200/JCO.2009.27.0652. Epub 2010 Jun 1.
9
Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations.林奇综合征患者结外癌症的累积终生发病率:121个已证实存在突变的家族报告
Clin Genet. 2009 Feb;75(2):141-9. doi: 10.1111/j.1399-0004.2008.01125.x.
10
The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside.林奇综合征中微卫星不稳定性、异常免疫组化及临床行为的生化基础:从实验室到临床
Fam Cancer. 2008;7(1):41-52. doi: 10.1007/s10689-007-9145-9. Epub 2007 Jul 17.